Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

Clinical trial NCT05024045 · COMPLETED

Trial details

NCT number: NCT05024045
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, B-cell Marginal Zone Lymphoma, Non-Hodgkin Multiple Myeloma B-cell Lymphoma Waldenstrom Macroglobulinemia Lymphoma, Mantle-Cell

Start date: 2021-09-30
Primary completion: 2023-06-14
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.